Myocardial Infarction News and Research

RSS

Adopting AI in diagnosis and prognosis of disease could help extend people's lives

The adoption of artificial intelligence in the diagnosis and prognosis of disease could help to extend people's lives whilst providing significant savings for the NHS.

30 Jan 2019

The type of saturated fats we eat can affect our cardiovascular heath

The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology.

29 Jan 2019

Type of saturated fats consumed could affect cardiovascular heath, analysis shows

The type of saturated fats we eat can affect our risk of a heart attack, according to a study published in the International Journal of Cardiology. People whose diets contain relatively little palmitic and stearic acid - saturated fats composed of 16 or more carbon atoms (longer-chain saturated fats) that are typically found in meats - and eat plant-based proteins instead have decreased chances of myocardial infarction.

28 Jan 2019

Study highlights need for reliable therapeutic targets for prevention, treatment of cardiovascular diseases

CVD (cardiovascular diseases) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke.

21 Jan 2019

Expression of a molecule in blood cells inversely predicts appearance of subclinical atherosclerosis

Earlier detection of cardiovascular disease is a step closer thanks to the findings of a research team at the Centro Nacional de Investigaciones Cardiovasculares led by Francisco Sánchez-Madrid and Pilar Martín.

10 Jan 2019

Cardiac events, stroke result in unemployment, lower income among survivors of working age

People who have experienced a heart attack (myocardial infarction), stroke or cardiac arrest are significantly less likely to be working than healthy people, and if they are working, on average have lower incomes, found a study published in CMAJ.

7 Jan 2019

Using untargeted metabolomics to find biomarkers and therapeutic targets for CVD

Cardiovascular diseases are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke. Efforts to prevent CVD have little effect on the decrease of the number of CVD related deaths despite many medical advances.

26 Dec 2018

Hospital readmission reduction program associated with increase in post-discharge mortality

A policy designed to reduce hospital readmissions through financial penalties was associated with a significant increase in post-discharge mortality for patients with heart failure and pneumonia, according to a large-scale study by researchers in Beth Israel Deaconess Medical Center's Smith Center for Outcomes Research in Cardiology.

21 Dec 2018

Review highlights calcium handling mechanisms involved in reperfusion injury

Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.

20 Dec 2018

New study adds evidence to efficacy and safety of low-dose vaginal estrogen

Despite its proven effectiveness in treating the genital symptoms of menopause, low-dose vaginal estrogen therapy remains underused largely because of misperceptions regarding its safety.

19 Dec 2018

Study may identify new diagnostics and treatment option for CVD

Forty-two percent of all deaths in the United States are related to cardiovascular disease. According to the Global Cardiovascular Drugs Market Forecast, by 2030 the number of deaths from CVD will rise to 23.6 million per year in the U.S. alone.

19 Dec 2018

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride in Brazil to Eurofarma Laboratorios S.A. Under this agreement, Eisai will supply Eurofarma with lorcaserin. Eisai will receive a one-time contractual payment and is eligible for milestone payments for sales in Brazil.

17 Dec 2018

Researchers compare health outcomes for VA and non-VA hospitals

The Veterans Health Administration is the largest integrated health care system in the United States, providing care at 1,243 health care facilities, including 172 VA Medical Centers and 1,062 outpatient sites.

10 Dec 2018

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke or cardiovascular death.

6 Dec 2018

Scientists find link between dietary salt intake and risk of developing common heart condition

Scientists have uncovered the first evidence to associate dietary salt intake with the risk of developing a common heart condition that affects millions of people worldwide, in a new study published in the Annals of Medicine.

4 Dec 2018

Second ACC Asia Conference to be held in Shanghai from November 30 to December 2, 2018

The American College of Cardiology will host the second ACC Asia Conference in Shanghai in collaboration with the China Cardiovascular Association and China Heart House from Nov. 30 - Dec. 2, 2018, bringing together top experts to discuss and review new, relevant cardiovascular science pertinent to the region.

29 Nov 2018

Study finds sex-specific differences in mechanisms that drive stress-induced myocardial ischemia

Some patients with coronary artery disease have inadequate blood flow to the heart muscle during periods of mental/emotional stress.

27 Nov 2018

Study reveals impact of residual inflammatory risk on clinical outcomes after PCI

Patients who have persistently high levels of inflammation following percutaneous coronary intervention for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of 7,026 patients published in the European Heart Journal.

19 Nov 2018

Diabetes medication reduces risk of heart failure hospitalization

In the largest trial to date to assess cardiovascular outcomes for an important class of diabetes medications, researchers have found that dapagliflozin markedly reduced the risk of hospitalization for heart failure in a broad population of patients with diabetes.

12 Nov 2018

Female smokers at greater risk of heart attacks, finds study

According to a large population study from the United Kingdom, women who smoke or those who have high blood pressure or diabetes are at a greater risk of heart attacks than men with same risks. The study results were published in the latest issue of the journal British Medical Journal.

8 Nov 2018